Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024
- Written by PR Newswire
![]() |
- Demonstrates Neurophet AQUA AD for AD treatments such as Leqembi and Kisunla
- Introduces updated version of Neurophet SCALE PET with centiloid scale feature
SEOUL, South Korea, July 25, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the Alzheimer's Association...
Read more: Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024















